← All stocks

VOLITIONRX LTD

VNRX Net buying
CIK 0000093314 #5385 in the set updated 20 Sep 2026
Bought (120 mo)
$4.21M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$787.80K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$787.80K
13 of 13 sales
Net
+$3.42M
+$3.42M against sales at will

By person

26 insiders · 124 transactions
3.0×

Cameron Reynolds holds only 3.0 times base salary in stock. $1.46M of shares against $473.94K in salary for 2025.

Salary from the company's own proxy. The shares are what Cameron Reynolds last reported holding, valued at $0.35, the price Common Stock was last bought or sold at on the open market here, on 17 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Innes Guy Archibald
Director
$2.11M (25)
+$2.11M
3,108,419
$1.09M
+179.1%
Faulkes Martin Charles
Executive Director
$822.18K (7)
$208.65K (1)
+$613.53K
2,096,207
$733.67K
+27.2%
Reynolds Cameron John
President and CEO
$381.76K (15)
+$381.76K
4,157,341
$1.46M
+113.6%
TERRELL JASON BRADLEY MD
Chief Medical Officer
$267.36K (9)
−$267.36K
33,192
$11.62K
−45.9%
Micallef Jacob Vincent
Chief Scientific Officer
$240.81K (9)
+$240.81K
725,405
$253.89K
+284.2%
Butera Salvatore Thomas
CEO - Volition Veterinary
$158.07K (12)
+$158.07K
375,203
$131.32K
STILL TIMOTHY I
Director
$74.52K (2)
+$74.52K
1,625,458
$568.91K
KRATOCHVIL DAVID MATTHEW
Chief Financial Officer
$50.00K (1)
+$50.00K
10,000
$3.50K
Eight Corp Ltd entity
10% owner
$284.57K (1)
$311.79K (3)
−$27.22K
12,662,170
$4.43M
−0.3%
Rootsaert Rodney Gerard
Secretary
$25.61K (3)
+$25.61K
1,281,711
$448.60K
+27.5%
Futcher Edward
Director
$13.30K (2)
+$13.30K
436,436
$152.75K
+14.0%
Plummer Nicholas
GC - Volition Diagnostics
$9.94K (1)
+$9.94K
407,267
$142.54K
+11,536%
Vanston David Cecil
Chief Financial Officer
$7.81K (1)
+$7.81K
2,750
$962.50
Barnes Phillip
Director
$6.50K (1)
+$6.50K
67,368
$23.58K
Nguyen Kim
Director
$6.40K (1)
+$6.40K
336,372
$117.73K
+983.1%
Michel Gaetan
Chief Operating Officer
$6.15K (1)
+$6.15K
256,746
$89.86K
Kway Jasmine
CEO - Singapore Volition
$6.00K (1)
+$6.00K
429,014
$150.15K
+7,845%
Henshall Mickie
Director
$4.63K (1)
+$4.63K
44,206
$15.47K
Hughes Terig
Chief Financial Officer
684,970
$239.74K
Forterre Gael
Chief Commercial Officer
331,338
$115.97K
+583.2%
Batchelor Ann-Louise
Group Chief Marketing Officer
324,072
$113.43K
+1,614%
Colman Alan
Director
257,364
$90.08K
+66.4%
Rubin Ethel
Director
252,948
$88.53K
Retter Andrew
Chief Medical Officer
146,568
$51.30K
Brudnick Richard
Director
27,936
$9.78K
Skaff Habib
Director
19,542
$6.84K
+28.7%

No percentages here. This company's share count has moved by a factor of 11.6 over the window, from 13,649,384 to 158,481,243 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Eight Corp Ltd
2 Jan 2024
10% owner
Sell indirect
20,000
$0.90
$18.00K
Eight Corp Ltd
15 Dec 2023
10% owner
Sell indirect
20,000
$0.75
$15.00K
TERRELL JASON BRADLEY MD
6 Jun 2022
Chief Medical Officer
Sell
14,949
$2.47
$36.92K
TERRELL JASON BRADLEY MD
11 Apr 2022
Chief Medical Officer
Sell
10,000
$2.75
$27.50K
TERRELL JASON BRADLEY MD
28 May 2021
Chief Medical Officer
Sell
10,000
$3.54
$35.40K
TERRELL JASON BRADLEY MD
5 Feb 2021
Chief Medical Officer
Sell
10,000
$5.37
$53.70K
TERRELL JASON BRADLEY MD
2 Dec 2020
Chief Medical Officer
Sell
10,000
$3.40
$34.00K
TERRELL JASON BRADLEY MD
18 Nov 2020
Chief Medical Officer
Sell
200
$3.45
$690.00
TERRELL JASON BRADLEY MD
18 Nov 2020
Chief Medical Officer
Sell
3,229
$3.35
$10.82K
TERRELL JASON BRADLEY MD
17 Nov 2020
Chief Medical Officer
Sell
1,571
$3.40
$5.34K
TERRELL JASON BRADLEY MD
15 Sep 2020
Chief Medical Officer
Sell
19,500
$3.23
$62.99K
Faulkes Martin Charles
9 Sep 2020
Director
Sell
65,000
$3.21
$208.65K
Eight Corp Ltd
26 Sep 2019
10% owner
Sell indirect
46,238
$6.03
$278.79K

What was left out

Form 4 filings counted 510
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 13,059,209
Sales filed before the plan box existed 11
History held since 15 Sep 2016